Advertisement.

ORIC Projected Dividend Yield

Oric Pharmaceuticals Inc ( NASDAQ : ORIC )

ORIC Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company which engaged in improving patients' lives by overcoming resistance in cancer. Co. develops therapies targeting hormone-dependent cancers, precision oncology, and key tumor dependencies. Co.'s clinical-stage products include ORIC-114, a brain-penetrant inhibitor targeting EGFR and HER2 for genetically defined cancers; ORIC-944, an allosteric inhibitor of PRC2 for prostate cancer; and ORIC-533, an orally bioavailable inhibitor of CD73, which plays a role in resistance to chemotherapy and immunotherapy.

21 YEAR PERFORMANCE RESULTS

ORIC Dividend History Detail
ORIC Dividend News
ORIC Competitors News

# of Shares: 0

Closing Price: 4.77

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2014	0.00	0%	0	$ 0.00	0.00%
2015	0.00	0%	0	$ 0.00	0.00%
2016	0.00	0%	0	$ 0.00	0.00%
2017	0.00	0%	0	$ 0.00	0.00%
2018	0.00	0%	0	$ 0.00	0.00%
2019	0.00	0%	0	$ 0.00	0.00%
2020	0.00	0%	0	$ 0.00	0.00%
2021	0.00	0%	0	$ 0.00	0.00%
2022	0.00	0%	0	$ 0.00	0.00%
2023	0.00	0%	0	$ 0.00	0.00%
2024	0.00	0%	0	$ 0.00	0.00%
2025	0.00	0%	0	$ 0.00	0.00%
2026	0.00	0%	0	$ 0.00	0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend $ Amount
Total:					0.0000